Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Interscalene Block

• Status: Completed
• Trial end date: 2019-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators compared between dexamethasone and dexmedetomidine when added to levobupivacaine in the quality and duration of ultrasound-guided interscalene block during shoulder arthroscopy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Menoufia University
• Collaborators: Basma Abdelhamid Fathy; Mamdoh Elsayed Lotfy; Osama Abdallah Elsharkawy
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate; Dexmedetomidine; Levobupivacaine

Criteria

Inclusion Criteria:

• Sixty healthy patients ASA I-II

• Aged 18-60 years

• Of both sexes

• Scheduled for shoulder arthroscopy using ultrasound interscalene block were enrolled.

Exclusion Criteria:

• Patients with a history of any allergic reactions to levobupivacaine, dexamethasone or α2 agonists

• All patients with hypertension, cardiac, hepatic, renal or pulmonary diseases, - Patients who were under treatment by α2 agonist or antagonists

• Pregnant women

• Psychiatric patients

• Patients with a previous history or clinical evidence of central or peripheral neurological disease

• Coagulopathy or anticoagulant/antiaggregant therapy

• Contralateral phrenic nerve paresis

• Patients who have an infection at the site of the block.

• Every patient who had an anatomical or vascular abnormality in the upper extremity were excluded from this study.